Clinical trial Recruiting at 7 sites Observational Ages 0 Months to 42 Months

Observational study on the health of children in protective services

Official title: PEGASE3, Experimental Program of a Standardized Health Protocol Applied to Children Who Benefited From a Child Protection Measure Before the Age of Five: Effectiveness and Efficiency

Run by Assistance Publique - Hôpitaux de Paris · NCT06805682 · Data updated 2026-11-12

This study looks at the health and development of children recently placed in protective services in France to see how a special health program helps them compared to those who don’t receive it.

More Child Development trials

Quick facts

Study typeObservational
Ages0 Months to 42 Months
SexAll
Enrollment220 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations7 sites (Évreux, France and 6 other locations)
StatusRecruiting
StartedFebruary 18, 2025
Main results expectedFebruary 17, 2029
Study endsFebruary 17, 2029
Registry record updatedApril 13, 2026
Trial IDNCT06805682 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children under 42 months old who are newly placed under the supervision of child protective services.

Probably not a fit

Children whose protective measures have not been confirmed by judicial or administrative decisions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the health status and developmental needs of children under the care of child protective services in France. It focuses on children who are newly placed in care and assesses their mental and physical health through standardized check-ups. The PEGASE program, funded by the French government, seeks to ensure adequate medical follow-up for these children, addressing both somatic and psychiatric needs. A control cohort will be created to compare outcomes between children receiving the PEGASE program and those who do not.

Why it matters

Potential benefit: If successful, this study could lead to improved health outcomes and better support for children in protective services.

How similar studies have gone: While there is limited data on similar studies, the approach of comprehensive health monitoring for vulnerable children is promising and has shown potential in other contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Child under the supervision of child protective services,
* Arriving for the first time in a participating center,
* Less than 42 months old (i.e. 3 and a half years),
* Non-opposition of the holders of parental authority (in the event of impossibility to obtain the non-opposition of both holders of parental authority, the non-opposition of one of them will be obtained).

Exclusion Criteria:

• Children whose child protection measure has not been confirmed by a judicial or administrative decision.

Where it's running

  • Maternal and Child Protection - The Eure Department
    Évreux, France, France
    Recruiting
  • Departmental institution to support - accompany - educate
    Lille, France, France
    Recruiting
  • Moselle Departmental Children's Centre
    Metz, France, France
    Recruiting
  • Maternal and Child Protection
    Rouen, France, France
    Recruiting
  • Maternal and Child Protection
    Saint-Brieuc, France, France
    Recruiting
  • Children and Family Home of the Loire
    Saint-Genest-Lerpt, France, France
    Recruiting
Show 1 more location
  • Departmental Observatory for Child Protection
    Toulon, France, France
    Recruiting

Study contacts

  • Principal investigator: Morgane MICHEL, MD — Clinical Epidemiology Unit, Robert Debré Hospital (Assistance Publique - Hôpitaux de Paris)
  • Study coordinator: Morgane MICHEL, MD
  • Email: morgane.michel@aphp.fr
  • Phone: +33 1 57 27 89 68

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.